Cytomegalovirus RetinitisGanciclovirCytomegalovirusCytomegalovirus InfectionsAntiviral AgentsFoscarnetRetinitisAIDS-Related Opportunistic InfectionsRetinitis PigmentosaAdministration, OralEye Infections, ViralThymidine KinaseMuromegalovirusAcquired Immunodeficiency SyndromeOrganophosphonatesInjections, IntravenousOrganophosphorus CompoundsCytosineDrug ImplantsInterleukin-10 Receptor alpha SubunitAcyclovirKidney TransplantationPhosphonoacetic AcidVitreous BodyDrug ToleranceHerpesviridae InfectionsTreatment OutcomeGraft SurvivalVisual AcuityGenetic TherapyCD4 Lymphocyte CountSafetyAntiretroviral Therapy, Highly ActiveSimplexvirusImmune ToleranceCytomegalovirus VaccinesInjectionsDNA, ViralGenes, Transgenic, SuicideProdrugsDrug Therapy, CombinationIntravitreal InjectionsProspective StudiesViral LoadOrgan TransplantationPhosphotransferases (Alcohol Group Acceptor)Genetic VectorsHerpesvirus 1, HumanViremiaTransplantation, HomologousViral ProteinsAntigens, ViralElectroretinographyCD4-Positive T-LymphocytesVirus ReplicationRibonucleosides